Research

GHK-Cu: Molecular Characterization and Coordination Chemistry — A Research Reference

GHK-Cu is a coordination complex rather than a peptide in the ordinary sense: a three-residue peptide paired with a copper(II) ion, whose solution structure and crystal structure were both resolved in the early 1980s [1, 2]. Nearly every question that arises in characterizing or handling it follows from the metal-binding chemistry rather than from the peptide backbone.

This page summarizes the complex's structural design, its coordination chemistry, and the analytical and handling considerations relevant to laboratory work with research-grade material.

Molecular Design and Structure

The peptide portion is glycyl-L-histidyl-L-lysine, written GHK in single-letter code. It is a tripeptide — very short by the standards of synthetic peptides, most of which run to thirty or forty residues — and its sequence corresponds to a segment of the alpha-2 chain of type I collagen rather than to a designed construct.

The distinguishing chemistry begins with the histidine. Three nitrogen donors are available in an arrangement that binds a divalent metal ion with high affinity: the imidazole nitrogen of the histidine side chain, the free amine at the amino terminus, and the deprotonated backbone amide nitrogen between the glycine and histidine residues. Copper(II) is the ion this arrangement holds most tightly.

Two structural determinations established the geometry. The solution structure, resolved by spectroscopic methods, established the donor set and the coordination arrangement in aqueous conditions [1]. A crystal structure at 1.1 Å resolution subsequently provided the atomic-level geometry of the complex in the solid state [2]. Together they define the entity that catalogue listings describe.

The free tripeptide and the copper complex are separate chemical species with separate registry entries and separate masses: the peptide alone sits near 340 daltons, the complex near 400. Which entity a nominal milligram figure describes is a question the batch certificate answers, not the product name.

Coordination Chemistry and Metal Binding

Copper(II) coordinated by this donor set adopts a near-square-planar geometry, and the complex carries a visible signature: absorption in the red region of the spectrum gives the material a blue to blue-violet colour rather than the white presented by most lyophilized peptides. That colour is a coarse but genuine identity indicator, and its absence in a vial nominally containing the complex is worth investigating rather than dismissing.

The lysine side chain does not participate in metal coordination. It remains free, and its basic amine contributes to the complex's solubility and to its behaviour across the pH range.

Binding is pH-dependent, as it is for all metal-peptide complexes relying on a deprotonated amide nitrogen: that nitrogen must lose its proton to coordinate, so complex formation and stability shift with acidity. Comparative work on modified GHK derivatives — where the tripeptide is conjugated to other scaffolds — has probed how the donor set tolerates structural change, and reports that copper(II) coordination is retained across a range of such modifications [3].

For laboratory work the practical consequence is that this is a metal complex first and a peptide second. Its stability constants, its spectroscopy, and its failure modes are those of coordination chemistry.

Analytical Characterization and Purity Verification

Mass spectrometry establishes identity by measuring the intact mass, and for this compound the measurement answers two questions at once: whether the tripeptide sequence is correct, and whether copper is present as coordinated metal rather than absent from a nominally complexed product. A result near 340 daltons and a result near 400 both look correct in isolation and describe different material.

Reversed-phase HPLC resolves the main peak from related substances and yields the purity figure. A three-residue sequence offers fewer opportunities for synthesis failure than a long chain, so the impurity profile is usually simple — but the chromatogram still merits inspection rather than reading the headline percentage alone.

Elemental analysis is the method that speaks to the copper specifically. Techniques such as inductively coupled plasma mass spectrometry quantify metal content directly, and the result can be compared against the theoretical proportion for a one-to-one complex. That figure is the direct evidence of stoichiometry and is not obtainable from a peptide purity assay.

Electronic absorption spectroscopy provides an orthogonal check available for this compound and few others in a peptide catalogue: the d-d absorption band responsible for the complex's colour reports on the coordination environment, and its position and intensity are diagnostic of the intended donor set [1].

Net peptide content accounts for counter-ions and residual water, determining how much material a nominal milligram figure represents.

Handling, Stability, and Storage

Sealed lyophilized material is stable at ambient temperature for the duration of transit and requires no cold chain in shipping. On receipt, vials are refrigerated and kept out of direct light.

One consideration is specific to metal complexes. Chelating agents compete for the copper, so glassware or solutions carrying residual EDTA or similar chelators from earlier procedures can strip the ion from the complex and leave the free tripeptide behind — an interference that is invisible until the material is analysed again. Dedicated or thoroughly rinsed labware avoids it.

Reconstituted material is held refrigerated and used within the window the receiving facility's protocols specify, and repeated freeze-thaw cycling is avoided. The short peptide chain is less prone to the aggregation that troubles long sequences, but the complex has its own vulnerability: coordinated copper is redox-active, so oxidising conditions and prolonged light exposure are more consequential here than for an ordinary peptide.

Regulatory and Research Status

GHK-Cu is an investigational compound. It has not been approved by the FDA or any other regulatory authority, and no manufacturing, labeling, or quality standards for an approved product apply to it. Research material is sold strictly for laboratory research use; it must not be administered to humans or animals. Researchers are responsible for compliance with all institutional and jurisdictional requirements governing research chemicals.

Each batch of research-grade GHK-Cu is accompanied by an independent certificate of analysis specific to that lot.

Summary

GHK-Cu is a one-to-one coordination complex of the tripeptide glycyl-L-histidyl-L-lysine with copper(II), bound through the histidine imidazole, the N-terminal amine, and a deprotonated backbone amide nitrogen in a near-square-planar geometry established by both solution and crystal structure determinations. Analytical verification rests on mass confirmation of the correct entity, direct quantitation of copper content, spectroscopic confirmation of the coordination environment, and batch-specific reporting of net content.

References

  1. Freedman JH, Pickart L, Weinstein B, et al. Biochemistry. 1982;21(19):4540–4544. doi:10.1021/bi00262a004
  2. Perkins CM, Rose NJ, Weinstein B, et al. Inorganica Chimica Acta. 1984;82(1):93–99. doi:10.1016/s0020-1693(00)82544-x
  3. Pettit L. J Inorg Biochem. 1992;45(3):203–210. doi:10.1016/0162-0134(92)80045-w

Citations follow a title-free numeric format. All external reference links carry rel="nofollow noopener". Content on this page describes molecular structure, coordination chemistry, and laboratory handling only, and is provided for research reference.